
### [MONDO:0016326](http://purl.obolibrary.org/obo/MONDO_0016326)
**Label:** lysosomal disease with hypertrophic cardiomyopathy

**Subclasses:** [MONDO:0016315](http://purl.obolibrary.org/obo/MONDO_0016315) (mucopolysaccharidosis type 2, severe form), [MONDO:0011759](http://purl.obolibrary.org/obo/MONDO_0011759) (Hurler-Scheie syndrome), [MONDO:0009562](http://purl.obolibrary.org/obo/MONDO_0009562) (beta-mannosidosis), [MONDO:0009254](http://purl.obolibrary.org/obo/MONDO_0009254) (fucosidosis), [MONDO:0017694](http://purl.obolibrary.org/obo/MONDO_0017694) (glycogen storage disease due to acid maltase deficiency, infantile onset), [MONDO:0018485](http://purl.obolibrary.org/obo/MONDO_0018485) (glycogen storage disease due to acid maltase deficiency, late-onset), [MONDO:0010674](http://purl.obolibrary.org/obo/MONDO_0010674) (mucopolysaccharidosis type 2), [MONDO:0011758](http://purl.obolibrary.org/obo/MONDO_0011758) (Hurler syndrome), [MONDO:0009290](http://purl.obolibrary.org/obo/MONDO_0009290) (glycogen storage disease II), [MONDO:0010526](http://purl.obolibrary.org/obo/MONDO_0010526) (Fabry disease), [MONDO:0016316](http://purl.obolibrary.org/obo/MONDO_0016316) (mucopolysaccharidosis type 2, attenuated form), 

**Mapped go classes:** [GO:0032450](http://purl.obolibrary.org/obo/GO_0032450) (maltose alpha-glucosidase activity), [GO:0048878](http://purl.obolibrary.org/obo/GO_0048878) (chemical homeostasis), [GO:0002086](http://purl.obolibrary.org/obo/GO_0002086) (diaphragm contraction), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0009311](http://purl.obolibrary.org/obo/GO_0009311) (oligosaccharide metabolic process), [GO:0060048](http://purl.obolibrary.org/obo/GO_0060048) (cardiac muscle contraction), [GO:0006004](http://purl.obolibrary.org/obo/GO_0006004) (fucose metabolic process), [GO:0004423](http://purl.obolibrary.org/obo/GO_0004423) (iduronate-2-sulfatase activity), [GO:0006516](http://purl.obolibrary.org/obo/GO_0006516) (glycoprotein catabolic process), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0051001](http://purl.obolibrary.org/obo/GO_0051001) (negative regulation of nitric-oxide synthase activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0052692](http://purl.obolibrary.org/obo/GO_0052692) (raffinose alpha-galactosidase activity), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0009888](http://purl.obolibrary.org/obo/GO_0009888) (tissue development), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0045019](http://purl.obolibrary.org/obo/GO_0045019) (negative regulation of nitric oxide biosynthetic process), [GO:0050884](http://purl.obolibrary.org/obo/GO_0050884) (neuromuscular process controlling posture), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0030135](http://purl.obolibrary.org/obo/GO_0030135) (coated vesicle), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0046716](http://purl.obolibrary.org/obo/GO_0046716) (muscle cell cellular homeostasis), [GO:0008484](http://purl.obolibrary.org/obo/GO_0008484) (sulfuric ester hydrolase activity), [GO:0004560](http://purl.obolibrary.org/obo/GO_0004560) (alpha-L-fucosidase activity), [GO:0046477](http://purl.obolibrary.org/obo/GO_0046477) (glycosylceramide catabolic process), [GO:0006941](http://purl.obolibrary.org/obo/GO_0006941) (striated muscle contraction), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0060347](http://purl.obolibrary.org/obo/GO_0060347) (heart trabecula formation), [GO:0006027](http://purl.obolibrary.org/obo/GO_0006027) (glycosaminoglycan catabolic process), [GO:0061316](http://purl.obolibrary.org/obo/GO_0061316) (canonical Wnt signaling pathway involved in heart development), [GO:0003940](http://purl.obolibrary.org/obo/GO_0003940) (L-iduronidase activity), [GO:0004557](http://purl.obolibrary.org/obo/GO_0004557) (alpha-galactosidase activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0004558](http://purl.obolibrary.org/obo/GO_0004558) (alpha-1,4-glucosidase activity), [GO:0030209](http://purl.obolibrary.org/obo/GO_0030209) (dermatan sulfate catabolic process), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0015928](http://purl.obolibrary.org/obo/GO_0015928) (fucosidase activity), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0016139](http://purl.obolibrary.org/obo/GO_0016139) (glycoside catabolic process), [GO:0007040](http://purl.obolibrary.org/obo/GO_0007040) (lysosome organization), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0016936](http://purl.obolibrary.org/obo/GO_0016936) (galactoside binding), [GO:0060536](http://purl.obolibrary.org/obo/GO_0060536) (cartilage morphogenesis), [GO:0005980](http://purl.obolibrary.org/obo/GO_0005980) (glycogen catabolic process), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0004574](http://purl.obolibrary.org/obo/GO_0004574) (oligo-1,6-glucosidase activity), [GO:0043181](http://purl.obolibrary.org/obo/GO_0043181) (vacuolar sequestering), [GO:0002026](http://purl.obolibrary.org/obo/GO_0002026) (regulation of the force of heart contraction), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0004567](http://purl.obolibrary.org/obo/GO_0004567) (beta-mannosidase activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005537](http://purl.obolibrary.org/obo/GO_0005537) (mannose binding), [GO:0005977](http://purl.obolibrary.org/obo/GO_0005977) (glycogen metabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030512](http://purl.obolibrary.org/obo/GO_0030512) (negative regulation of transforming growth factor beta receptor signaling pathway), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [GO:0052692](http://purl.obolibrary.org/obo/GO_0052692) (raffinose alpha-galactosidase activity) 52.27%
- [GO:0032450](http://purl.obolibrary.org/obo/GO_0032450) (maltose alpha-glucosidase activity) 52.27%
- [GO:0004574](http://purl.obolibrary.org/obo/GO_0004574) (oligo-1,6-glucosidase activity) 52.27%
- [GO:0004558](http://purl.obolibrary.org/obo/GO_0004558) (alpha-1,4-glucosidase activity) 52.27%
- [GO:0004557](http://purl.obolibrary.org/obo/GO_0004557) (alpha-galactosidase activity) 52.27%
- [GO:0003940](http://purl.obolibrary.org/obo/GO_0003940) (L-iduronidase activity) 52.27%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) 42.17%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 42.17%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 42.17%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 42.17%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 42.17%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 42.17%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 42.17%
- [GO:0090599](http://purl.obolibrary.org/obo/GO_0090599) (alpha-glucosidase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 42.17%


